Intensive, long-term blood pressure-lowering treatment reduced the risk of recurrent stroke by 38%, without increasing serious adverse events, in people who have survived an intracerebral haemorrhage (ICH). The… read more.
The results show a need for nuanced communication between doctors and patients. “Always finish your antibiotics” is no longer considered medical best practice for all conditions. Surprised? You’re… read more.
Jazz Pharmaceuticals plc announced that the U.S. Food and Drug Administration (FDA) approved two Ziihera (zanidatamab-hrii)-containing regimens for the first-line treatment of adults with unresectable locally advanced or… read more.
Ultragenyx Pharmaceutical announced that the FDA granted accelerated approval for Genglycos (pariglasgene brecaparvovec-opnr), also known as DTX 401, in adult and pediatric patients eight years and older with… read more.
Men are more likely than women to catch tuberculosis (TB), finds a new study led by UCL (University College London) researchers. Globally, men account for around two-thirds of… read more.
An international study has found that despite two decades of global tobacco control efforts, the message still is not getting through to enough smokers that smoking and second-hand… read more.
Capricor Therapeutics announced that the FDA has extended the Prescription Drug User Fee Act (PDUFA) target action date for its Biologics License Application (BLA) for Deramiocel, an investigational… read more.
Positive topline results from the DESTINY-Lung04 phase 3 trial showed Enhertu (trastuzumab deruxtecan) demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) versus global standard… read more.
Menstrual leave and flexible work arrangements are the forms of support women with endometriosis say would help them most, according to a new study by researchers at Semmelweis University published… read more.
Johnson & Johnson announced U.S. 510(k) regulatory clearance for MONARCH QUEST 3, the latest software update for the MONARCH Platform. The update reflects the company’s continued commitment to… read more.
A new study published in Diabetes Care finds that bone loss alone does not explain the increased fracture risk observed in some older adults with type 2 diabetes. The article, “Type… read more.
A new study of sunscreens, baby lotions, shampoos, soaps, and other everyday products found that nearly all contained chemicals not disclosed on their labels. Most contained at least one unlabeled… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
